124
Views
21
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

The Use of Exhaled Nitric Oxide in the Management of Asthma

&
Pages 523-531 | Published online: 02 Jul 2009

References

  • Gibson P G, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax February, 2002; 57(2)178–182
  • Brightling C E, Ward R, Goh K L, Wardlaw A J, Pavord I D. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med August, 1999; 160(2)406–410
  • Brightling C E, Monteiro W, Ward R, Parker D, Morgan M D, Wardlaw A J, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet October 28, 2000; 356(9240)1480–1485
  • Rosi E, Ronchi M C, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol February, 1999; 103(2)232–237, Pt 1
  • Brightling C E, Ward R, Wardlaw A J, Pavord I D. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J April, 2000; 15(4)682–686
  • Pavord I D, Brightling C E, Woltmann G, Wardlaw A J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet June 26, 1999; 353(9171)2213–2214
  • Pizzichini E, Pizzichini M M, Gibson P, Parameswaran K, Gleich G J, Berman L, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med November, 1998; 158(5)1511–1517, Pt 1
  • Berry M A, Morgan A, Shaw D E, Parker D, Bradding P, Green R H, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62: 1043–1049
  • Jayaram L, Pizzichini M M, Cook R J, Boulet L P, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J March, 2006; 27(3)483–494
  • Green R H, Brightling C E, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet November 30, 2002; 360(9347)1715–1721
  • Siva R, Green R H, Brightling C E, Shelley M, Hargadon B, McKenna S, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J May, 2007; 29(5)906–913
  • Palmer R M, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature June 11, 1987; 327(6122)524–526
  • Ignarro L J, Buga G M, Wood K S, Byrns R E, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA December, 1987; 84(24)9265–9269
  • Gustafsson L E, Leone A M, Persson M G, Wiklund N P, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun December 16, 1991; 181(2)852–857
  • Alving K, Weitzberg E, Lundberg J M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J October, 1993; 6(9)1368–1370
  • Kharitonov S A, Yates D H, Barnes P J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med January, 1996; 153(1)454–457
  • Guo F H, Comhair S A, Zheng S, Dweik R A, Eissa N T, Thomassen M J, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol June 1, 2000; 164(11)5970–5980
  • Kobzik L, Bredt D S, Lowenstein C J, Drazen J, Gaston B, Sugarbaker D, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol October, 1993; 9(4)371–377
  • Tracey W R, Xue C, Klinghofer V, Barlow J, Pollock J S, Forstermann U, et al. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol June, 1994; 266(6)L722–L727, Pt 1
  • Liu C Y, Wang C H, Chen T C, Lin H C, Yu C T, Kuo H P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer August, 1998; 78(4)534–541
  • Wang C H, Liu C Y, Lin H C, Yu C T, Chung K F, Kuo H P. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J April, 1998; 11(4)809–815
  • Furukawa K, Harrison D G, Saleh D, Shennib H, Chagnon F P, Giaid A. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med February, 1996; 153(2)847–850
  • Rosbe K W, Mims J W, Prazma J, Petrusz P, Rose A, Drake A F. Immunohistochemical localization of nitric oxide synthase activity in upper respiratory epithelium. Laryngoscope September, 1996; 106(9)1075–1079, Pt 1
  • Furukawa K, Harrison D G, Saleh D, Shennib H, Chagnon F P, Giaid A. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med February, 1996; 153(2)847–850
  • Stuehr D J, Cho H J, Kwon N S, Weise M F, Nathan C F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD-and FMN-containing flavoprotein. Proc Natl Acad Sci USA September 1, 1991; 88(17)7773–7777
  • Ding A H, Nathan C F, Stuehr D J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol October 1, 1988; 141(7)2407–2412
  • Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol April, 1991; 49(4)380–387
  • Morris S M, Jr., Billiar T R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol June, 1994; 266(6)E829–E839, Pt 1
  • Sheu F S, Zhu W, Fung P C. Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy. Biophys J March, 2000; 78(3)1216–1226
  • Stamler J S, Simon D I, Osborne J A, Mullins M E, Jaraki O, Michel T, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA January 1, 1992; 89(1)444–448
  • van's Gravesande K S, Wechsler M E, Grasemann H, Silverman E S, Le L, Palmer L J, et al. Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med July 15, 2003; 168(2)228–231
  • Gao P S, Kawada H, Kasamatsu T, Mao X Q, Roberts M H, Miyamoto Y, et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun January 27, 2000; 267(3)761–763
  • Henriksen A H, Sue-Chu M, Lingaas H T, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J February, 1999; 13(2)301–306
  • Lundberg J O, Weitzberg E, Lundberg J M, Alving K. Nitric oxide in exhaled air. Eur Respir J December, 1996; 9(12)2671–2680
  • Kharitonov S, Alving K, Barnes P J. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J July, 1997; 10(7)1683–1693
  • Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med December, 1999; 160(6)2104–2117
  • ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med April 15, 2005; 171(8)912–930
  • Gruffyd-Jones K, Ward S, Stonham C, Macfarlane T V, Thomas M. The use of exhaled nitric oxide monitoring in primary care asthma clinics: a pilot study. Primary Care Respir J 2007, in press
  • Kharitonov S A, Gonio F, Kelly C, Meah S, Barnes P J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J March, 2003; 21(3)433–438
  • Tsoukias N M, George S C. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol August, 1998; 85(2)653–666
  • Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J June, 2005; 25(6)986–991
  • Silkoff P E, Sylvester J T, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med April, 2000; 161(4)1218–1228, Pt 1
  • Tsoukias N M, George S C. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol August, 1998; 85(2)653–666
  • Kharitonov S A, Gonio F, Kelly C, Meah S, Barnes P J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J March, 2003; 21(3)433–438
  • Tornberg D C, Marteus H, Schedin U, Alving K, Lundberg J O, Weitzberg E. Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients. Eur Respir J May, 2002; 19(5)859–864
  • Isono S, Morrison D L, Launois S H, Feroah T R, Whitelaw W A, Remmers J E. Static mechanics of the velopharynx of patients with obstructive sleep apnea. J Appl Physiol July, 1993; 75(1)148–154
  • Isono S, Shimada A, Utsugi M, Konno A, Nishino T. Comparison of static mechanical properties of the passive pharynx between normal children and children with sleep-disordered breathing. Am J Respir Crit Care Med April, 1998; 157(4)1204–1212, Pt 1
  • Adrie C, Monchi M, Dinh-Xuan A T, Dall'Ava-Santucci J, Dhainaut J F, Pinsky M R. Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients. Am J Respir Crit Care Med April, 2001; 163(5)1143–1149
  • Balfour-Lynn I M, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child October, 1996; 75(4)319–322
  • Buchvald F, Baraldi E, Carraro S, Gaston B, De J J, Pijnenburg M W, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol June, 2005; 115(6)1130–1136
  • Olin A C, Rosengren A, Thelle D S, Lissner L, Bake B, Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest November, 2006; 130(5)1319–1325
  • Kharitonov S A, Logan-Sinclair R B, Busset C M, Shinebourne E A. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J September, 1994; 72(3)243–245
  • Borrill Z, Clough D, Truman N, Morris J, Langley S, Singh D. A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med August, 2006; 100(8)1392–1396
  • Payne D N, Adcock I M, Wilson N M, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med October 15, 2001; 164(8)1376–1381, Pt 1
  • Warke T J, Fitch P S, Brown V, Taylor R, Lyons J D, Ennis M, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax May, 2002; 57(5)383–387
  • Mattes J, Storm van's G K, Reining U, Alving K, Ihorst G, Henschen M, et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J June, 1999; 13(6)1391–1395
  • Piacentini G L, Bodini A, Costella S, Vicentini L, Mazzi P, Sperandio S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J June, 1999; 13(6)1386–1390
  • Jatakanon A, Lim S, Kharitonov S A, Chung K F, Barnes P J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax February, 1998; 53(2)91–95
  • Berlyne G, Barnes N. No role for NO in asthma?. Lancet March 25, 2000; 355(9209)1029–1030
  • Berlyne G S, Parameswaran K, Kamada D, Efthimiadis A, Hargreave F E. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol October, 2000; 106(4)638–644
  • Silvestri M, Spallarossa D, Frangova Y V, Battistini E, Fregonese B, Rossi G A. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur Respir J February, 1999; 13(2)321–326
  • Strunk R, Szefler S, Phillips B, Zeiger R, Chinchilli V, Larsen G, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol November, 2003; 112(5)883–892
  • Covar R A, Szefler S J, Martin R J, Sundstrom D A, Silkoff P E, Murphy J, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr May, 2003; 142(5)469–475
  • Steerenberg P A, Janssen N A, de Meer G, Fischer P H, Nierkens S, van Loveren H, et al. Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children. Thorax March, 2003; 58(3)242–245
  • Lim S, Jatakanon A, Meah S, Oates T, Chung K F, Barnes P J. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax March, 2000; 55(3)184–188
  • Turktas H, Oguzulgen K, Kokturk N, Memis L, Erbas D. Correlation of exhaled nitric oxide levels and airway inflammation markers in stable asthmatic patients. J Asthma June, 2003; 40(4)425–430
  • Haldar P, Shaw D, Siva R, Berry M, Brightling C, Green R, et al. The correlation between exhaled nitric oxide and sputum eosinophil counts in patients with airway disease. Thorax 2008; 62: A128
  • Jatakanon A, Kharitonov S, Lim S, Barnes P J. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax February, 1999; 54(2)108–114
  • Massaro A F, Gaston B, Kita D, Fanta C, Stamler J S, Drazen J M. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med August, 1995; 152(2)800–803
  • Kharitonov S A, Yates D, Robbins R A, Logan-Sinclair R, Shinebourne E A, Barnes P J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet January 15, 1994; 343(8890)133–135
  • Kharitonov S A, O'Connor B J, Evans D J, Barnes P J. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med June, 1995; 151(6)1894–1899
  • Jones S L, Herbison P, Cowan J O, Flannery E M, Hancox R J, McLachlan C R, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J September, 2002; 20(3)601–608
  • Kharitonov S A, Donnelly L E, Montuschi P, Corradi M, Collins J V, Barnes P J. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax October, 2002; 57(10)889–896
  • Crimi E, Spanevello A, Neri M, Ind P W, Rossi G A, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med January, 1998; 157(1)4–9
  • Green R H, Brightling C E, Woltmann G, Parker D, Wardlaw A J, Pavord I D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax October, 2002; 57(10)875–879
  • Jones S L, Kittelson J, Cowan J O, Flannery E M, Hancox R J, McLachlan C R, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med September 1, 2001; 164(5)738–743
  • Leuppi J D, Salome C M, Jenkins C R, Anderson S D, Xuan W, Marks G B, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med February, 2001; 163(2)406–412
  • Deykin A, Lazarus S C, Fahy J V, Wechsler M E, Boushey H A, Chinchilli V M, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol April, 2005; 115(4)720–727
  • Harkins M S, Fiato K L, Iwamoto G K. Exhaled nitric oxide predicts asthma exacerbation. J Asthma June, 2004; 41(4)471–476
  • Zacharasiewicz A, Wilson N, Lex C, Erin E M, Li A M, Hansel T, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med May 15, 2005; 171(10)1077–1082
  • Pijnenburg M W, Hofhuis W, Hop W C, de Jongste J C. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax March, 2005; 60(3)215–218
  • Smith A D, Cowan J O, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med February 15, 2004; 169(4)473–478
  • Berkman N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax May, 2005; 60(5)383–388
  • Dupont L J, Demedts M G, Verleden G M. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest March, 2003; 123(3)751–756
  • Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med August 1, 2007; 176(3)238–242
  • Brightling C E, Ward R, Wardlaw A J, Pavord I D. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J April, 2000; 15(4)682–686
  • Smith A D, Cowan J O, Brassett K P, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med August 15, 2005; 172(4)453–459
  • Bateman E D, Boushey H A, Bousquet J, Busse W W, Clark T J, Pauwels R A, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med October 15, 2004; 170(8)836–844
  • Jayaram L, Pizzichini M M, Cook R J, Boulet L P, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J March, 2006; 27(3)483–494
  • Smith A D, Cowan J O, Brassett K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med May 26, 2005; 352(21)2163–2173
  • de Jongste J C. Yes to NO: the first studies on exhaled nitric oxide-driven asthma treatment. Eur Respir J September, 2005; 26(3)379–381
  • Pijnenburg M W, Bakker E M, Hop W C, de Jongste J C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med October 1, 2005; 172(7)831–836
  • Shaw D E, Berry M A, Thomas M, Green R H, Brightling C E, Wardlaw A J, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med August 1, 2007; 176(3)231–237
  • Juniper E F, Bousquet J, Abetz L, Bateman E D. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med April, 2006; 100(4)616–621
  • Taylor D R, Pijnenburg M W, Smith A D, de Jongste J C. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax September, 2006; 61(9)817–827
  • Mcivor R A, Pizzichini E, Turner M O, Hussack P, Hargreave F E, Sears M R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med September, 1998; 158(3)924–930

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.